November 4-5 2026
Hynes Convention Center, Boston USA

ADVANCING CELL AND GENE THERAPIES

Sponsor
or exhibit

Tickets from $445
Register now

THE FUTURE OF ADVANCED THERAPIES

1,200+

Attendees

200+

Speakers

50+

Exhibitors

50+

Biotech Start-Ups

2

Days

Speaker line-up

Ricardo Baptista
Chief Technology Officer
Smartcella
Cecile Bauche
CSO
Alaya.bio
Roy Baynes
Executive Vice President and Chief Medical Officer
Eikon Therapeutics
Anne Brooks
SVP, Global Access, Operations and Proleukin
Iovance Biotherapeutics
James Carroll
President and CEO
RNA Nanobiotics
Preet Chaudhary
CEO
Angeles Therapeutics
Fred Chereau
SVP Strategy and Business Development
Alexion Pharmaceuticals
Caralynn Collens
CEO
Dimension Bio
Colleen Dansereau
Vice President, Emerging Discoveries, Gene Therapy Operations
Boston Children's Hospital
Maurits Geerlings
President & CEO
NanoCell Therapeutics
Brett Howard
Senior Director, US Regulatory Policy
United States Pharmacopeia
Scott Jeffers
Chief Technology Officer
GenSight Biologics
Koby Kidder
Head of R&D, Co-Inventor
BobcatBio
Eric Kmiec
Founder & CEO
Corrixr Therapeutics
Tom Leitch
CTO
KSQ Therapeutics, Inc.
Yan Li
Senior Director, Process Development
Cabaletta Bio
Chris Mason
Professor, Cell & Gene Therapy
University College London
Joshua McGee
CSO & Co-founder
Keylicon Biosciences
Dara Missan
Lead Engineer, QC
Mayo clinic
David Morrow
Scientific Lead for Advanced Therapies
EATRIS
Vanessa Almendro Navarro
Chief Commercialization Officer
City of Hope
Cokey Nguyen
President and CEO
Atara Biotherapeutics
Raphael Ognar
President & CEO, Co-founder
NKILT Therapeutics Inc.
Shahrooz Rabizadeh
CEO & Co-Founder
Sagittarius Bio, Inc
Tay Salimullah
Venture Partner
4BIO Capital
Kelli Tea
Head of Commercial
Cartesian Therapeutics
Jie Wei
Director, Bioanalytical Sciences
Tr1x, Inc

About Advanced Therapies Congress USA

The Advanced Therapies Congress is America's most exciting cell and gene therapy conference and exhibition. The event is designed for the leaders of pioneering ATMP companies and their most senior executives in charge of the latest tech and strategies that are driving the industry forward.

The conference brings together a community of 1,200 global executives at the Hynes Convention Center, Boston, to be inspired by 200 speakers and 50 start-ups over 2 incredible days. The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and start-up companies, researchers, clinicians, academics, HTAs, payers and regulators.

2026 Keynotes

Wednesday 4th November

From Pipeline to Patients: Reflections on the gene therapy development journey

Keynote Panel Discussion: Navigating the Cell and Gene Therapy Landscape: Opportunities & Challenges for Driving Market Success

Thursday 5th November

An Integrated Engine for Advanced Therapies: City of Hope Partner-Ready Engine for Clinical Translation

Keynote Panel Discussion: Where’s the Money? Evolution And Future Outlook for Investment in Advanced Therapies

Sponsors include

Apply to Sponsor/Exhibit

What is the Advanced Therapies Congress?

Conference

The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development with 8 tracks of content over 2 days.

SEE LATEST SPEAKERS

Exhibition

50 leading solution providers to meet your needs across all stages of cell and gene therapy development

DOWNLOAD PROSPECTUS

Networking

Connect with thousands of cell and gene therapy experts in 12+ hours of built-in 1-2-1 networking

GET YOUR TICKET NOW

Covering the entire pipeline of ATMPs

The Advanced Therapies Congress brings together speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and startup companies, researchers, clinicians, academics, HTAs, payers, regulators.

Get your ticket now

America's most exciting commercial cell and gene therapy conference

Evidence, Pricing & Access

Ensuring clinical success
Tackling large scale regulatory challenges
Finding the right framework for reimbursement and market access
Cross-border healthcare
Outcome based agreements
Tackling large scale regulatory challenges
Patient informed policy decisions

Gene Modified Cell Therapy

Autologous vs allogeneic
Tackling solid tumours
Combination therapy
CAR-T, NK, Gamma-Delta cells
Patient stratification and precision medicine approaches

Cell Therapy

Stem cells
Regenerative Medicine
MSCs vs iPSCs
Cord blood advancements

Gene Therapy

Next generation of gene therapy
Moving from rare to more common diseases
Tackling immunogenicity
Rare diseases & orphan drugs
Novel gene delivery systems
Gene editing

Cell Therapy Manufacturing

Automation & closed systems
Scaling up to commercial level
Keeping costs low
In house vs outsourcing

Viral Vector Manufacturing

Continuous manufacturing
Scaling up for commercial production
In house vs outsourcing

Supply Chain & Logistics

Logistics, transportation, distribution & cold chain
Moving from clinical to commercial
Patient experience
Supply chain
Point of care delivery

Innovation Showcase

Latest in academic research
Latest cutting-edge technologies success

GET YOUR TICKETS NOW

DOWNLOAD PROSPECTUS

"Very insightful and cutting-edge talks and panel discussions"

– Consultant, ProPharma Group

"Great chance to connect with relevant people from the ecosystem"

– Head of Investment, Govt of Catalonia

"The event attracts a wide range of great people from across the industry. It is a fantastic networking opportunity"

– Senior Scientist, Rinri Therapeutics

Join us in Philadelphia | November 18-19 2025

TICKETS FROM $245
GET YOUR TICKETS NOW

SPONSOR OR EXHIBIT

Get Involved with the Advanced Therapies Congress

To sponsor or exhibit

Natasha Bangle
natasha.bangle@terrapinn.com
+44 20 3545 5515

To speak

Chris Shanks
chris.shanks@terrapinn.com
+02034332221